United Kingdom· GB-APID-37764711000001105
Singulair Paediatric 4mg granules sachets
A montelukast product containing montelukast, registered in United Kingdom by CST Pharma Ltd. The same ATC class is registered in 19 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Montelukast is registered in 19 of 19 countries.
Countries holding a registration under ATC R03DC03 (montelukast), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 11 of them publish a price we can compare per daily dose
Montelukast · ATC R03DC03
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of montelukast costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.59 in Italy to $1.71 in Spain — a ×2.9 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Montelukast · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- ES Spain$1.71
- CH Switzerland$1.41
- FR France$0.71
- IT Italy$0.59
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Montelukast
- Manufacturer
- CST Pharma Ltd
- Country
- United Kingdom (GB)
- ATC code
- R03DC03
- ATC class
- Montelukast
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5055946806853
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
565 interactions on record for montelukast.
Graded by severity as the source publishes them — 101 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Montelukast · interactions on record
565 records
- 101 moderate
- 464 info
Most severe, free to view
- MiconazoleA07AC01moderate
- TroglitazoneA10BG01moderate
- NateglinideA10BX03moderate
- NitisinoneA16AX04moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under R03DC03
Montelukast, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c0c3a9a9-0481-46b4-8694-8cb5ee42dd47 GET /v1/drugs/c0c3a9a9-0481-46b4-8694-8cb5ee42dd47?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "37764711000001105",
"desc": "Singulair Paediatric 4mg granules sachets (CST Pharma Ltd)",
"form": "Oral granules",
"vpid": "42296511000001104",
"source": "dmd",
"vtm_id": "776824002",
"strength": "4 mg",
"substance": "Montelukast",
"ingredient": "Montelukast sodium",
"supplier_code": "24059811000001102"
}See everything about montelukast.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.